| Document and Entity Information | Feb. 02, 2022 |
| Document And Entity Information [Line Items] | |
| Amendment Flag | true |
| Entity Central Index Key | 0001822691 |
| Document Type | 8-K/A |
| Document Period End Date | Feb. 2, 2022 |
| Entity Registrant Name | GREENLIGHT BIOSCIENCES HOLDINGS, PBC |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-39894 |
| Entity Tax Identification Number | 85-1914700 |
| Entity Address, Address Line One | 200 Boston Avenue |
| Entity Address, Address Line Two | Suite 3100 |
| Entity Address, City or Town | Medford |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02155 |
| City Area Code | (617) |
| Local Phone Number | 616-8188 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Amendment Description | This amendment to Current Report on Form 8-K (this “Form 8-K/A”) updates and amends the Current Report on Form 8-K (the “Original Form 8-K”) filed on February 7, 2022 by GreenLight Biosciences Holdings, PBC (“New GreenLight”) solely to provide supplemental financial information that was not required to be included in the Original Form 8-K but that relates to financial periods that concluded before the consummation of the transactions reported in the Original Form 8-K. |
| Common Class A [Member] | |
| Document And Entity Information [Line Items] | |
| Security 12b Title | Common Stock, par value $0.0001 per share |
| Trading Symbol | GRNA |
| Security Exchange Name | NASDAQ |
| Warrant [Member] | |
| Document And Entity Information [Line Items] | |
| Security 12b Title | Warrants, each exercisable for one share of Common Stock for $11.50 per share |
| Trading Symbol | GRNAW |
| Security Exchange Name | NASDAQ |
